Shigeo Horie

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt et al. · Kidney International · 2015 · 582 citations · Full text

Urology, Renal Disease, Renal Function +13

Focal Therapy with High-intensity-focused Ultrasound in the Treatment of Localized Prostate Cancer

Satoru Muto, Takashi Yoshii, Keisuke Saito et al. · Japanese Journal of Clinical Oncology · 2008 · 200 citations · Full text

Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen

Hisamitsu Ide, Shino Tokiwa, Kentaro Sakamaki et al. · The Prostate · 2010 · 176 citations

<i>Kdm6a</i> Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with <i>p53</i> Dysfunction

Kohei Kobatake, Kenichiro Ikeda, Yuichiro Nakata et al. · Clinical Cancer Research · 2020 · 168 citations

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease

Eiji Higashihara, Vicente E. Torres, Arlene B. Chapman et al. · Clinical Journal of the American Society of Nephrology · 2011 · 148 citations · Full text